Skip to main content

Advertisement

SpringerLink
Log in

Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim: To evaluate the association of metabolic syndrome (MetS) and its individual components with microvascular complications and coronary artery calcification (CAC) in patients with Type 1 diabetes. Material/Subjects and methods: Cross-sectional study included 261 patients with Type 1 diabetes. Patients were assessed regarding the presence of MetS according to National Cholesterol Education Program (NCEP) criteria. CAC score was measured in a subset of 100 patients without known cardiovascular disease. Results: The prevalence of MetS was 13.4% according to the NCEP criteria. Microvascular complications and CAC were more frequent in patients with MetS. In a multiple logistic regression analysis, MetS remained associated with nephropathy [OR: 6.33 (95% CI 2.54–15.77), p<0.001], but not with retinopathy and CAC. Among the MetS components, hypertension was associated with presence of retinopathy [OR: 4.04 (95% CI 1.65–9.90), p=0.002], nephropathy [OR: 5.92 (95% CI 2.42–14.4), p<0.001] and CAC [OR: 2.97 (95% CI 1.06–8.30), p=0.03]. Conclusions: Hypertension was the only MetS component associated with retinopathy, nephropathy and the presence of CAC. Hypertension was better associated with CAC than MetS itself.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Isomaa B, Almgren P, Tuom T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24: 683–9.

    Article  CAS  PubMed  Google Scholar 

  2. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288: 2709–16.

    Article  PubMed  Google Scholar 

  3. Costa LA, Canani LH, Lisbôa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 2004, 21: 252–5.

    Article  CAS  PubMed  Google Scholar 

  4. Kahn R. Metabolic syndrome — What is the clinical usefulness? Lancet 2008, 48: 1679–83.

    Google Scholar 

  5. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005, 21: 1157–9.

    Article  PubMed  Google Scholar 

  6. Bonora E, Targher G, Formentini G, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 2004, 21: 52–8.

    Article  CAS  PubMed  Google Scholar 

  7. The Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006, 29: 2701–7.

    Article  Google Scholar 

  8. Thorn LM, Forsblom C, Fagerudd J, et al. Metabolic syndrome in type 1 diabetes. Association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005, 28: 2019–24.

    Article  PubMed  Google Scholar 

  9. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. The Pittsburgh Epidemiology of Diabetes Complications study experience. Diabetes Care 2007, 30: 1248–54.

    Article  PubMed  Google Scholar 

  10. Davis TME, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study. Diabetes Res Clin Pract 2007, 78: 412–7.

    Article  PubMed  Google Scholar 

  11. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. “Double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care 2007, 30: 707–12.

    Article  CAS  PubMed  Google Scholar 

  12. Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. 10 years follow-up data from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care 2003, 26: 1374–9.

    Article  PubMed  Google Scholar 

  13. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006, 114: 1761–91.

    Article  PubMed  Google Scholar 

  14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486–97.

    Article  Google Scholar 

  15. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney: evaluation, classification, and stratification. Ann Intern Med 2003, 139: 137–47.

    Article  PubMed  Google Scholar 

  16. Williams KV, Erbey JR, Becker D, Arsianian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000, 49: 626–32.

    Article  CAS  PubMed  Google Scholar 

  17. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993, 342: 883–7.

    Article  CAS  PubMed  Google Scholar 

  18. Chillaron JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab 2009, 94: 3530–4.

    Article  CAS  PubMed  Google Scholar 

  19. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998, 31: 126–33.

    Article  CAS  PubMed  Google Scholar 

  20. Schurgin S, Rich S, Mazzone T. Increased of prevalence coronary artery calcification in patients with diabetes. Diabetes Care 2001, 24: 335–8.

    Article  CAS  PubMed  Google Scholar 

  21. Tzou W, Douglas P, Srinivasan SR, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome. The Bogalusa Heart Study. J Am Coll Cardiol 2005, 46: 457–63.

    Article  CAS  PubMed  Google Scholar 

  22. Wong ND, Sciammarella MG, Polk D, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003, 41: 1547–53.

    Article  CAS  PubMed  Google Scholar 

  23. Thorn LM, Forsblom C, Waden J, et al. The metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2009, 32: 950–2.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease. Med Clin North Am 2005, 89: 689–99.

    Article  PubMed  Google Scholar 

  25. Thomas MC, Rosengard-Barlund M, Mills V, et al. Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes. Diabetes Care 2006, 29: 317–22.

    Article  CAS  PubMed  Google Scholar 

  26. Sjolie AK, Stephenson J, Aldington S, et al. Retinopathy and vision loss in insulin dependent diabetes in Europe: the EURODIAB IDDM Complications Study. Ophthalmology 1997, 104: 252–60.

    Article  CAS  PubMed  Google Scholar 

  27. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and the effect of initial anti-hypertensive treatment. Scand Clin Lab Invest 1976, 36: 383–8.

    Article  CAS  Google Scholar 

  28. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000, 148: 159–69.

    Article  CAS  PubMed  Google Scholar 

  29. Da Costa Rodrigues T, Pecis M, Azevedo MJ, Esteves JF, Gross JL. Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: A 6-year follow-up study. Diabetes Res Clin Pract 2006, 74: 135–40.

    Article  PubMed  Google Scholar 

  30. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994, 271: 275–9.

    Article  CAS  PubMed  Google Scholar 

  31. Kramer CK, Von Mühlen D, Gross JL, Barrett-Connor E. A prospective study of abdominal obesity and coronary artery calcium progression in older adults. J Clin Endocrinol Metab 2009, 94: 5039–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kramer CK, Von Mühlen D, Gross JL, Laughlin GA, Barrett-Connor E. Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: The Rancho Bernardo study. Diabetes Care 2009, 32: 141–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre

    T. C. Rodrigues MD, PhD, L. H. Canani & J. L. Gross

  2. Radiology Division, Hospital Moinhos de Vento, Porto Alegre, Brazil

    P. Schvartzman

Authors
  1. T. C. Rodrigues MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. H. Canani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Schvartzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. L. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. C. Rodrigues MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodrigues, T.C., Canani, L.H., Schvartzman, P. et al. Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in Type 1 diabetes. J Endocrinol Invest 34, e58–e63 (2011). https://doi.org/10.1007/BF03347077

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347077

Key-words

Search

Navigation